Nonclinical Safety

Key responsibilities

Strategic leadership & portfolio impact

Lead the nonclinical safety strategy across Ailux’s pipeline

Shape candidate selection and go/no-go decisions through integrated mechanistic and translational safety assessment, balancing target biology, therapeutic index, exposure margins and clinical risk.

Partner closely with DMPK, bioscience, translational and clinical teams to integrate PK/PD, exposure-response and safety data into human dose prediction and first-in-human strategy

Partner with Platform Science teams to evaluate and optimise emerging technologies.